ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $360 | -16.9% | 17,288 | -4.3% | 0.03% | -20.6% |
| Q2 2023 | $433 | +22.0% | 18,068 | -4.2% | 0.03% | +30.8% |
| Q1 2023 | $355 | -23.5% | 18,867 | -35.3% | 0.03% | -33.3% |
| Q4 2022 | $464 | -99.9% | 29,170 | +6.4% | 0.04% | -7.1% |
| Q3 2022 | $448,000 | +24.1% | 27,407 | +7.0% | 0.04% | +27.3% |
| Q2 2022 | $361,000 | +28.9% | 25,621 | +121.4% | 0.03% | +266.7% |
| Q1 2022 | $280,000 | +58.2% | 11,573 | +8.4% | 0.01% | +28.6% |
| Q3 2021 | $177,000 | – | 10,673 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |